NO20062781L - Eksipienter i legemiddelleveringsvehikler - Google Patents
Eksipienter i legemiddelleveringsvehiklerInfo
- Publication number
- NO20062781L NO20062781L NO20062781A NO20062781A NO20062781L NO 20062781 L NO20062781 L NO 20062781L NO 20062781 A NO20062781 A NO 20062781A NO 20062781 A NO20062781 A NO 20062781A NO 20062781 L NO20062781 L NO 20062781L
- Authority
- NO
- Norway
- Prior art keywords
- polymers
- excipients
- drug delivery
- delivery vehicles
- gel preparations
- Prior art date
Links
- 239000000546 pharmaceutical excipient Substances 0.000 title abstract 3
- 238000012377 drug delivery Methods 0.000 title 1
- 239000000499 gel Substances 0.000 abstract 3
- 229920000642 polymer Polymers 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 229920013641 bioerodible polymer Polymers 0.000 abstract 1
- 239000003638 chemical reducing agent Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000003002 pH adjusting agent Substances 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 230000000087 stabilizing effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51997203P | 2003-11-14 | 2003-11-14 | |
US10/985,116 US20050281879A1 (en) | 2003-11-14 | 2004-11-10 | Excipients in drug delivery vehicles |
PCT/US2004/037606 WO2005048989A1 (fr) | 2003-11-14 | 2004-11-12 | Excipients pour transport de medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20062781L true NO20062781L (no) | 2006-08-14 |
Family
ID=34623114
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20062781A NO20062781L (no) | 2003-11-14 | 2006-06-14 | Eksipienter i legemiddelleveringsvehikler |
Country Status (14)
Country | Link |
---|---|
US (1) | US20050281879A1 (fr) |
EP (1) | EP1691785A4 (fr) |
JP (1) | JP2007511516A (fr) |
KR (1) | KR20060125748A (fr) |
AR (1) | AR046842A1 (fr) |
AU (2) | AU2004291077A1 (fr) |
BR (1) | BRPI0416032A (fr) |
CA (1) | CA2545913C (fr) |
IL (1) | IL175601A0 (fr) |
MX (1) | MXPA06005464A (fr) |
NO (1) | NO20062781L (fr) |
PE (1) | PE20050494A1 (fr) |
TW (1) | TW200524631A (fr) |
WO (1) | WO2005048989A1 (fr) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003295409B2 (en) * | 2002-11-06 | 2010-02-11 | Durect Corporation | Controlled release depot formulations |
US7731947B2 (en) | 2003-11-17 | 2010-06-08 | Intarcia Therapeutics, Inc. | Composition and dosage form comprising an interferon particle formulation and suspending vehicle |
US20050106214A1 (en) * | 2003-11-14 | 2005-05-19 | Guohua Chen | Excipients in drug delivery vehicles |
WO2006083761A2 (fr) | 2005-02-03 | 2006-08-10 | Alza Corporation | Solutions de solvant/polymere utilisees comme vehicules de suspension |
US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
CA2614006C (fr) * | 2005-07-02 | 2014-11-04 | Arecor Limited | Systemes aqueux stables comprenant des proteines |
US20070027105A1 (en) | 2005-07-26 | 2007-02-01 | Alza Corporation | Peroxide removal from drug delivery vehicle |
AU2013202598B2 (en) * | 2005-09-30 | 2016-06-09 | Durect Corporation | Sustained release small molecule drug formulation |
US8852638B2 (en) * | 2005-09-30 | 2014-10-07 | Durect Corporation | Sustained release small molecule drug formulation |
KR101106510B1 (ko) | 2006-05-30 | 2012-01-20 | 인타르시아 세라퓨틱스 인코포레이티드 | 투피스, 내부채널 삼투압 전달 시스템 유동 조절기 |
DK2049081T3 (da) | 2006-08-09 | 2013-02-25 | Intarcia Therapeutics Inc | Osmotiske leveringssystemer og stempelarrangementer |
ES2402172T3 (es) | 2007-04-23 | 2013-04-29 | Intarcia Therapeutics, Inc | Formulación en suspensión de péptidos insulinotrópicos y usos de los mismos |
EP2167039B1 (fr) | 2007-05-18 | 2016-09-28 | Durect Corporation | Formulations à dépôt amélioré |
CA2687979C (fr) | 2007-05-25 | 2017-07-04 | Tolmar Therapeutics, Inc. | Formulations d'administration prolongee de composes de risperidone |
US20110027172A1 (en) * | 2007-12-10 | 2011-02-03 | Zhuang Wang | Drug delivery system for pharmaceuticals and radiation |
EP2240155B1 (fr) | 2008-02-13 | 2012-06-06 | Intarcia Therapeutics, Inc | Dispositifs, formulations et méthodes d administration de plusieurs agents bénéfiques |
US8956642B2 (en) * | 2008-04-18 | 2015-02-17 | Medtronic, Inc. | Bupivacaine formulation in a polyorthoester carrier |
US20100016808A1 (en) * | 2008-07-17 | 2010-01-21 | Bioform Medical, Inc. | Thin-Walled Delivery System |
ES2344674B1 (es) * | 2008-08-07 | 2011-06-29 | Gp Pharm, S.A. | Composicion farmaceutica inyectable de taxanos. |
CN107638562B (zh) | 2009-09-28 | 2022-12-02 | 精达制药公司 | 基本稳态药物递送的快速建立和/或终止 |
US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
EP2841105A4 (fr) * | 2012-03-30 | 2016-12-21 | Nanunanu Ltd | Gels de phosphate de magnésium |
UA116217C2 (uk) | 2012-10-09 | 2018-02-26 | Санофі | Пептидна сполука як подвійний агоніст рецепторів glp1-1 та глюкагону |
CN104870009B (zh) | 2012-12-21 | 2021-05-18 | 赛诺菲 | 官能化的毒蜥外泌肽-4衍生物 |
US20140308352A1 (en) | 2013-03-11 | 2014-10-16 | Zogenix Inc. | Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material |
US9737605B2 (en) | 2013-03-11 | 2017-08-22 | Durect Corporation | Injectable controlled release composition comprising high viscosity liquid carrier |
US20160303242A1 (en) | 2013-12-09 | 2016-10-20 | Durect Corporation | Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same |
EP3080154B1 (fr) | 2013-12-13 | 2018-02-07 | Sanofi | Agonistes doubles du récepteur glp-1/gip |
EP3080152A1 (fr) | 2013-12-13 | 2016-10-19 | Sanofi | Analogues peptidiques de l'exendine 4 non acylés |
EP3080149A1 (fr) | 2013-12-13 | 2016-10-19 | Sanofi | Agonistes mixtes des récepteurs du glp-1/glucagon |
TW201609795A (zh) | 2013-12-13 | 2016-03-16 | 賽諾菲公司 | 作為雙重glp-1/gip受體促效劑的艾塞那肽-4(exendin-4)胜肽類似物 |
TW201625668A (zh) | 2014-04-07 | 2016-07-16 | 賽諾菲公司 | 作為胜肽性雙重glp-1/昇糖素受體激動劑之艾塞那肽-4衍生物 |
TW201625669A (zh) | 2014-04-07 | 2016-07-16 | 賽諾菲公司 | 衍生自艾塞那肽-4(Exendin-4)之肽類雙重GLP-1/升糖素受體促效劑 |
TW201625670A (zh) | 2014-04-07 | 2016-07-16 | 賽諾菲公司 | 衍生自exendin-4之雙重glp-1/升糖素受體促效劑 |
US9932381B2 (en) | 2014-06-18 | 2018-04-03 | Sanofi | Exendin-4 derivatives as selective glucagon receptor agonists |
US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
AU2015341490C1 (en) | 2014-11-07 | 2021-03-11 | Indivior Uk Limited | Buprenorphine dosing regimens |
KR20170129170A (ko) * | 2015-03-18 | 2017-11-24 | 산텐 세이야꾸 가부시키가이샤 | 서방성 의약 조성물 |
US10925639B2 (en) | 2015-06-03 | 2021-02-23 | Intarcia Therapeutics, Inc. | Implant placement and removal systems |
AR105319A1 (es) | 2015-06-05 | 2017-09-27 | Sanofi Sa | Profármacos que comprenden un conjugado agonista dual de glp-1 / glucagón conector ácido hialurónico |
US20180185489A1 (en) * | 2015-07-01 | 2018-07-05 | Santen Pharmaceutical Co., Ltd. | Depot preparation containing citric acid ester |
TW201706291A (zh) | 2015-07-10 | 2017-02-16 | 賽諾菲公司 | 作為選擇性肽雙重glp-1/升糖素受體促效劑之新毒蜥外泌肽(exendin-4)衍生物 |
CN105295310A (zh) * | 2015-11-11 | 2016-02-03 | 苏州国泰科技发展有限公司 | 一种绿色环保型增塑剂 |
BR112018073511A2 (pt) | 2016-05-16 | 2019-03-26 | Intarcia Therapeutics, Inc. | polipeptídeos seletivos do receptor de glucagon e métodos de uso dos mesmos |
USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
MX2019008006A (es) | 2017-01-03 | 2019-08-29 | Intarcia Therapeutics Inc | Metodos que comprenden la administracion continua de un agonista del receptor de glp-1 y la co-administracion de un farmaco. |
US10646484B2 (en) | 2017-06-16 | 2020-05-12 | Indivior Uk Limited | Methods to treat opioid use disorder |
CA3167217A1 (fr) | 2020-01-13 | 2021-07-22 | Durect Corporation | Systemes d'administration de medicament a liberation prolongee avec impuretes reduites et procedes associes |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US630200A (en) * | 1899-03-13 | 1899-08-01 | Draper Co | Warp-stop-motion mechanism. |
US4443340A (en) * | 1981-10-09 | 1984-04-17 | Betz Laboratories, Inc. | Control of iron induced fouling in water systems |
US4985404A (en) * | 1984-10-04 | 1991-01-15 | Monsanto Company | Prolonged release of biologically active polypeptides |
US4853218A (en) * | 1987-02-24 | 1989-08-01 | Schering Corporation | Zinc-protamine-alpha interferon complex |
US4938763B1 (en) * | 1988-10-03 | 1995-07-04 | Atrix Lab Inc | Biodegradable in-situ forming implants and method of producing the same |
US5656297A (en) * | 1992-03-12 | 1997-08-12 | Alkermes Controlled Therapeutics, Incorporated | Modulated release from biocompatible polymers |
US5912015A (en) * | 1992-03-12 | 1999-06-15 | Alkermes Controlled Therapeutics, Inc. | Modulated release from biocompatible polymers |
DE69311538D1 (de) * | 1992-03-12 | 1997-07-17 | Alkermes Inc | Acth enthaltende mikrokugeln mit gesteuerter abgabe |
US5711968A (en) * | 1994-07-25 | 1998-01-27 | Alkermes Controlled Therapeutics, Inc. | Composition and method for the controlled release of metal cation-stabilized interferon |
US20030035845A1 (en) * | 1992-06-11 | 2003-02-20 | Zale Stephen E. | Composition for sustained release of non-aggregated erythropoietin |
US5242910A (en) * | 1992-10-13 | 1993-09-07 | The Procter & Gamble Company | Sustained release compositions for treating periodontal disease |
ES2151541T3 (es) * | 1992-12-02 | 2001-01-01 | Alkermes Inc | Microesferas que contienen hormona del crecimiento de liberacion prolongada. |
KR100374098B1 (ko) * | 1994-04-08 | 2003-06-09 | 아트릭스 라보라토리스, 인코포레이션 | 조절된방출이식편형성에적합한액체전달조성물 |
US5626862A (en) * | 1994-08-02 | 1997-05-06 | Massachusetts Institute Of Technology | Controlled local delivery of chemotherapeutic agents for treating solid tumors |
US6184227B1 (en) * | 1995-07-21 | 2001-02-06 | Savvipharm Inc. | Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases |
US5801012A (en) * | 1996-09-17 | 1998-09-01 | Northwestern University | Methods and compositions for generating angiostatin |
EP0959873B1 (fr) * | 1996-12-20 | 2006-03-01 | ALZA Corporation | Procedes et composition a base de gel |
US6113947A (en) * | 1997-06-13 | 2000-09-05 | Genentech, Inc. | Controlled release microencapsulated NGF formulation |
JP3077635B2 (ja) * | 1997-06-20 | 2000-08-14 | 日本電気株式会社 | 高速無線アクセス装置 |
AU1928399A (en) * | 1998-12-18 | 2000-07-12 | Angiosonics, Inc. | Method for prevention and treatment of cancer and other cell proliferative diseases with ultrasonic energy |
US20030211974A1 (en) * | 2000-03-21 | 2003-11-13 | Brodbeck Kevin J. | Gel composition and methods |
CA2446060A1 (fr) * | 2001-05-07 | 2002-11-14 | Corium International | Compositions et systemes d'administration d'un anesthesique local |
EP1446100B1 (fr) * | 2001-11-14 | 2011-05-04 | Durect Corporation | Compositions en depot injectables et utilisations |
NZ533436A (en) * | 2001-11-14 | 2007-10-26 | Alza Corp | Catheter injectable depot compositons and uses thereof |
WO2003041685A1 (fr) * | 2001-11-14 | 2003-05-22 | Alza Corporation | Composition pour injection retard |
US20040001889A1 (en) * | 2002-06-25 | 2004-01-01 | Guohua Chen | Short duration depot formulations |
US20050106214A1 (en) * | 2003-11-14 | 2005-05-19 | Guohua Chen | Excipients in drug delivery vehicles |
-
2004
- 2004-11-10 US US10/985,116 patent/US20050281879A1/en not_active Abandoned
- 2004-11-12 AU AU2004291077A patent/AU2004291077A1/en not_active Abandoned
- 2004-11-12 BR BRPI0416032-0A patent/BRPI0416032A/pt not_active IP Right Cessation
- 2004-11-12 JP JP2006539843A patent/JP2007511516A/ja active Pending
- 2004-11-12 CA CA2545913A patent/CA2545913C/fr not_active Expired - Fee Related
- 2004-11-12 MX MXPA06005464A patent/MXPA06005464A/es unknown
- 2004-11-12 KR KR1020067009218A patent/KR20060125748A/ko not_active Application Discontinuation
- 2004-11-12 WO PCT/US2004/037606 patent/WO2005048989A1/fr active Application Filing
- 2004-11-12 EP EP04819090A patent/EP1691785A4/fr not_active Withdrawn
- 2004-11-12 PE PE2004001114A patent/PE20050494A1/es not_active Application Discontinuation
- 2004-11-12 TW TW093134556A patent/TW200524631A/zh unknown
- 2004-11-15 AR ARP040104211A patent/AR046842A1/es not_active Application Discontinuation
-
2006
- 2006-05-11 IL IL175601A patent/IL175601A0/en unknown
- 2006-06-14 NO NO20062781A patent/NO20062781L/no not_active Application Discontinuation
-
2011
- 2011-05-02 AU AU2011201972A patent/AU2011201972B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
EP1691785A1 (fr) | 2006-08-23 |
MXPA06005464A (es) | 2006-08-11 |
BRPI0416032A (pt) | 2007-01-02 |
US20050281879A1 (en) | 2005-12-22 |
EP1691785A4 (fr) | 2012-08-29 |
TW200524631A (en) | 2005-08-01 |
CA2545913C (fr) | 2013-12-31 |
AR046842A1 (es) | 2005-12-28 |
PE20050494A1 (es) | 2005-08-24 |
WO2005048989A1 (fr) | 2005-06-02 |
AU2004291077A1 (en) | 2005-06-02 |
IL175601A0 (en) | 2006-09-05 |
KR20060125748A (ko) | 2006-12-06 |
CA2545913A1 (fr) | 2005-06-02 |
JP2007511516A (ja) | 2007-05-10 |
AU2011201972A1 (en) | 2011-05-19 |
AU2011201972B2 (en) | 2013-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20062781L (no) | Eksipienter i legemiddelleveringsvehikler | |
NO20062780L (no) | Eksipienter i legemiddelleveringsvehikler | |
ATE389385T1 (de) | Ophthalmische depot-formulierungen zur periokkularen oder subkonjunktivalen verabreichung | |
PT1144459E (pt) | Acidos hialuronicos reticulados e as suas utilizacoes em medicina | |
MXPA02012164A (es) | Derivados de tiofeno activos como inhibidores de cinasa, proceso para su preparacion y composiciones farmaceuticas que los comprenden. | |
CY1116463T1 (el) | Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης | |
TW200605915A (en) | Drug delivery compositions | |
CY1105319T1 (el) | Ταχεως αποσαθρουμενη απο του στοματος συνταγοποιηση του valdecoxib | |
AR032293A1 (es) | Estuche farmaceutico | |
CY1107838T1 (el) | Παραγωγα αδαμαντανιου για τη θεραπεια φλεγμονωδων, ανοσολογικων και καρδιαγγειακων ασθενειων | |
ATE450252T1 (de) | Arzneimittel-mikroteilchen | |
CA2430995A1 (fr) | Systeme de gelification reversible pour distribution de medicaments oculaires | |
CY1105120T1 (el) | Η αντιμετωπιση αναπνευστικων νοσων | |
DK1061900T3 (da) | Dermale præparater | |
ES2138271T3 (es) | Compuestos de 6-dimetil-amino-metil-1-fenil-ciclohexano como principio activo farmaceutico. | |
WO2004000389A3 (fr) | Microperforateur a dissolution rapide pour administration de produits pharmaceutiques et autres applications | |
NO20014035L (no) | System for oral administrasjon av medikament | |
CY1107465T1 (el) | Μελαγατρανη για τη θepαπευτικη αντιμετωπιση φλεγμονων | |
BR0308486A (pt) | Composição tópica compreendendo um ciclofrutano, um veìculo e uma droga | |
AU2003238221A1 (en) | Ibuprofen suspension | |
MY130332A (en) | Pharmaceutical formulation comprising iota-carrageenan and at least one neutral gelling polymer | |
MXPA05009719A (es) | Derivados de biciclo-pirazol activos como inhibidores de cinasa, procedimiento para su preparacion y composiciones farmaceuticas que los comprenden. | |
DK1280558T3 (da) | Halvfast indgivelsesvehikel og farmaceutiske sammensætninger | |
AU2002316221A1 (en) | Methods for inducing sustained immune response | |
BR0112258A (pt) | Sistema de entrega de droga para drogas pouco solúveis em água |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |